Position in MRNA
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$543,782
+$89,326 QoQ
Shares Held
7,765
-13.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#368
of 777 holders
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Caprock Group, LLC holds $29,990,834 across 34 Biotechnology names. MRNA ranks #7 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
33,721 | $16,750,232 | |
| 2 | JAZZ |
Jazz Pharmaceuticals plc
|
8,663 | $2,087,523 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,437 | $1,519,566 | |
| 4 | ARGX |
Argenx SE
|
1,543 | $1,431,549 | |
| 5 | AUPH |
Aurinia Pharmaceuticals Inc.
|
44,542 | $755,877 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
3,115 | $583,377 | |
| 7 | MRNA |
Moderna, Inc.
This page
|
7,765 | $543,782 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
3,712 | $455,016 |
All Filings in MRNA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $543,782 | 7,765 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $454,456 | 8,946 | Shares | Sole | 2026-05-11 | |
| 2025-09-30 | $358,623 | 13,884 | Shares | Sole | 2025-11-06 | |
| 2024-12-31 | $203,159 | 4,886 | Shares | Sole | 2025-01-23 | |
| 2024-06-30 | $608,237 | 5,122 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $328,417 | 3,082 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $244,746 | 2,461 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $258,534 | 2,503 | Shares | Sole | 2023-10-18 | |
| No filing history on record for this holder in this stock. | ||||||